Last reviewed · How we verify

NCT07372248

Thermal Artifact in Patients Undergoing Conization: A Clinical Study

Recruiting now NA Last updated 2 March 2026
What this trial tests

NA trial testing Conization with Electrosurgery diffferent power settings in Cervix Neoplasm in 150 participants. Currently enrolling.

Timeline
23 February 2026
Primary endpoint
30 April 2026
30 December 2026

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment150
Start date23 February 2026
Primary completion30 April 2026
Estimated completion30 December 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

18 and older, female only, with Cervix Neoplasm or Cervix, Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cervical transformation zone excision is commonly used in the diagnosis and treatment of cervical intraepithelial neoplasia. Thermal artifacts can negatively affect histopathological evaluation. This study compares three different modifications of conization performed using electrosurgery in terms of the degree of thermal artifacts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervix Neoplasm

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07372248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing